Literature DB >> 2986845

Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins.

B Blumberg, C Giorgi, L Roux, R Raju, P Dowling, A Chollet, D Kolakofsky.   

Abstract

The nucleotide sequence of the Sendai virus (SV) HN (hemagglutinin-neuraminidase) gene was determined. The deduced primary structure of the protein showed only one hydrophobic domain likely to represent the transmembrane region, but at its N terminus. Since the SV F protein is anchored in the membrane at its C terminus, the two SV glycoproteins are thus membrane-anchored in opposite orientations, similar to the two influenza virus (FLU) glycoproteins. Amino acid sequence comparisons of the SV HN and the FLU HA and NA proteins revealed homologies between 100 amino acids of the hemagglutinin region of the FLU HA protein and the C terminus of the SV HN, and between 200 amino acids of the neuraminidase region of the FLU NA and the central region of SV HN. Alignment of the neuraminidase, hemagglutinin, and fusion regions shared by these glycoproteins suggest the structure of a possible ancestral gene.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986845     DOI: 10.1016/0092-8674(85)90080-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  41 in total

1.  Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.

Authors:  R M Iorio; R J Syddall; J P Sheehan; M A Bratt; R L Glickman; A M Riel
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  The haemagglutinin-neuraminidase glycoprotein of the porcine paramyxovirus LPMV: comparison with other paramyxoviruses revealed the closest relationship to simian virus 5 and mumps virus.

Authors:  A Sundqvist; M Berg; J Moreno-López; T Linné
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  Sequence analysis of temperature sensitive and "neuraminidase-tolerant" mutants of Newcastle disease virus (strain Beaudette C).

Authors:  J Hughes; K Yusoff; R Hardy; H McCartney; P T Emmerson; A C Samson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.

Authors:  K L van Wyke Coelingh; C C Winter; E D Jorgensen; B R Murphy
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

5.  Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies.

Authors:  K J Coelingh; C C Winter; B R Murphy; J M Rice; P C Kimball; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Cloning and sequencing of the HN gene of Sendai virus (strain Fushimi).

Authors:  W J Neubert; W Willenbrink
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

7.  Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus.

Authors:  S D Thompson; W G Laver; K G Murti; A Portner
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins.

Authors:  T Shioda; K Iwasaki; H Shibuta
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

9.  Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein.

Authors:  N Ishida; H Taira; T Omata; K Mizumoto; S Hattori; K Iwasaki; M Kawakita
Journal:  Nucleic Acids Res       Date:  1986-08-26       Impact factor: 16.971

10.  A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

Authors:  T Sakaguchi; K Kiyotani; M Sakaki; Y Fujii; T Yoshida
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.